Home › Cidara Therapeutics Inc (CDTX) Rating Lowered to Hold at Zacks Investment Research
 

Keywords :   


Cidara Therapeutics Inc (CDTX) Rating Lowered to Hold at Zacks Investment Research

2016-03-25 03:28:33| Biotech - Topix.net

According to Zacks, "Cidara Therapeutics, Inc. is a biotechnology company. The company is focused on the discovery, development and commercialization of novel anti-infectives.

Tags: research rating hold investment

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.11 EVA 6
23.11 8
23.11SEVENTEEN ALWAYS YOURS Weverse 13
23.11 DX
23.11 No.23/1998
23.11 DVD 9
23.11
23.11 CD His Melody
More »